LABDANIC BITERPENES IN LIPOSOME FORM; STUDIES IN HUMAN LEUCAEMIC CELL SERIES OF THE NEW LIPOSOME PRODUCTS IN VITRO

摘要

The present invention relates to the enclosure of Labdanic biterpenes in liposomes. The aim is the development of new anticancer medicines using all advantages stemming from liposome technology.Labdanic biterpenes Labd-13(E)-ene, 8a-15diol (1); Labd-13(E)-ene, 8a15yl acetate (2), Sclareol (3), manoyl oxide mixture of isomers (4), 3